Mirum Pharmaceuticals Inc (MIRM)
26.15
-0.07
(-0.27%)
USD |
NASDAQ |
May 23, 12:23
Mirum Pharmaceuticals Debt to Equity Ratio: 1.308 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 1.308 |
December 31, 2023 | 1.232 |
September 30, 2023 | 1.137 |
June 30, 2023 | 3.888 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
Date | Value |
---|---|
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2021
3.888
Maximum
Jun 2023
0.6304
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 651.96M |
Total Liabilities (Quarterly) | 417.36M |
Shareholders Equity (Quarterly) | 234.60M |
Current Ratio | 3.677 |
Net Debt Paydown Yield | -5.19% |